Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes

PURPOSE: The purpose of this study was to investigate the activity of capecitabine and trastuzumab in patients with HER2-overexpressing metastatic breast caner resistant to both anthracyclines and taxanes. METHOD: From June 2003 and May 2006, 40 female patients with measurable or assessable metastat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishida, Takanori, Kiba, Takayoshi, Takeda, Motohiro, Matsuyama, Kotone, Teramukai, Satoshi, Ishiwata, Ryota, Masuda, Norikazu, Takatsuka, Yuichi, Noguchi, Shinzaburo, Ishioka, Chikashi, Fukushima, Masanori, Ohuchi, Noriaki
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2008
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688618/
https://www.ncbi.nlm.nih.gov/pubmed/19082596
http://dx.doi.org/10.1007/s00280-008-0882-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688618/
https://www.ncbi.nlm.nih.gov/pubmed/19082596
http://dx.doi.org/10.1007/s00280-008-0882-8

Ejemplares similares